For digital health to be more widely implemented across the healthcare industry, smaller biopharma companies must be the first to demonstrate its efficacy. In this way, they must deliver specific real-world cases to prove to bigger pharma companies that digital health solutions are viable for the clinical R&D industry.
Do you agree? Disagree? Check out this clip from our latest Pharma15 Live! debate, and leave a comment below.